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Abstract
Human plasma has long been a rich source for biomarker discovery. It has recently become clear that plasma RNA
molecules, such as microRNA, in addition to proteins are common and can serve as biomarkers. Surveying human plasma
for microRNA biomarkers using next generation sequencing technology, we observed that a significant fraction of the
circulating RNA appear to originate from exogenous species. With careful analysis of sequence error statistics and other
controls, we demonstrated that there is a wide range of RNA from many different organisms, including bacteria and fungi as
well as from other species. These RNAs may be associated with protein, lipid or other molecules protecting them from
RNase activity in plasma. Some of these RNAs are detected in intracellular complexes and may be able to influence cellular
activities under in vitro conditions. These findings raise the possibility that plasma RNAs of exogenous origin may serve as
signaling molecules mediating for example the human-microbiome interaction and may affect and/or indicate the state of
human health.
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Introduction
Many novel biological insights have emerged from the analysis
of DNA and RNA sequences. Important discoveries, such as
various pathology-causing variants in the human genome and the
history of human migration, were made possible by the availability
of sequencing technology [1,2,3]. Normal human physiology is the
result of a well-orchestrated balance between genetic (intrinsic) and
environmental (extrinsic) factors, and the availability of the
complete human genome sequence facilitates the study of complex
human-environmental interactions. Recently this has included the
human-microbiome interaction, especially the gut microbiome [4].
These microbes interact intimately with gut epithelium and the
alteration in the spectrum of the gut microbiome has been linked
to various physiopathological conditions, such as diarrhea, obesity,
and inflammatory pathologies as well as to the general state of
health [5,6].
The recent development of highly parallelized next generation
(NextGen) sequencing technologies has further advanced the use
of sequencing as a tool in studying complex biological systems by
genome sequencing and transcriptome analysis [7,8,9,10]. One
advantage of using a sequence-based approach for transcriptome
analysis is the ability to identify novel transcripts, such as
alternative usage of exons or polyadenylation sites of known
transcripts. The recent explosion of information on microRNA
(miRNA) and other noncoding RNAs (ncRNAs) is the result in
part of applying these new technologies. MiRNAs are transcribed
from genome by processes similar to protein-coding genes. The
primary miRNA transcripts are processed in the nucleus and later
in the cytosol by the RNase III enzymes Drosha and Dicer,
respectively [11]. Typically, one strand of this mature miRNA
duplex then associates with the RNA-induced silencing complex
(RISC) where it interacts with its messenger RNA (mRNA) targets.
To date more than 1000 different human miRNA species have
been identified (see miRBase, www.mirbase.org). Recently, a
significant number of these RNA molecules have been observed in
the extracellular environment and have been implicated as
important mediators in cell-cell communication [4,12,13].
Results
Low Fraction of Mappable Sequence Reads from Plasma
Samples
Because of the shortcomings of existing miRNA measuring
systems, we adapted the NextGen sequencing technology to obtain
more accurate spectra of these important molecules in circulation,
specifically to explore the plasma-miRNA association with
colorectal cancer and ulcerative colitis. Initially we conducted
NextGen sequencing on 9 plasma samples: 3 samples from healthy
individuals, 3 from patients with colorectal cancer prior to any
treatment and 3 from individuals suffering from ulcerative colitis
(Mayo Score between 10 and 11) (Table S1). Sequence reads were
preprocessed and then aligned to known human miRNAs, human
transcripts and human genome sequence. The concentration of
PLOS ONE | www.plosone.org 1 December 2012 | Volume 7 | Issue 12 | e51009
several miRNAs in plasma showed differences among normal and
patients with either colorectal cancer or ulcerative colitis. We
conducted quantitative polymerase chain reaction (QPCR) mea-
surements to validate some of these miRNAs (Figures S1a and
S1b).
On first examination, we noticed that less than 1.5% of the
processed reads actually mapped to human miRNAs. About 11%
of the remaining reads mapped to human transcripts and human
genome sequence when no sequence mismatch was allowed (Table
S3). With a higher tolerance of sequence mismatches, the fraction
of reads that can be mapped to known human transcripts rose to
about 42% and 15% to other human genomic sequences (under
two mismatch allowance). However, this still leaves over 40% of
the processed reads with an unknown origin.
To ensure our protocol is effectively mapping back the reads to
transcript and genome sequences, a NextGen sequence read
simulator, ART [14] (http://bioinformatics.joyhz.com/ART/),
was used to generate artificial transcriptome data. With a 2
mismatch allowance, over 98% of the sequences from our
simulated dataset can be mapped to the corresponding transcrip-
tome (Table S4). This provided some assurance that our protocol
can map most (,98%) of the NextGen sequencing data under 2
mismatch allowance.
Human Plasma Contains a Significant Amount of
Exogenous RNA
In order to identify the origin of those unmapped sequences in
our sequencing results and to ensure that there was no error
introduced in preparing the sequencing library that could account
for the unknowns, we conducted a systematic search against
various sequence databases. We used a ‘‘map and remove’’
approach to analyze the sequence (Figure 1). The processed
sequences were first screened against endogenous (human)
sequence databases including known human miRNA, human
transcripts, followed by human genomic sequence. Except for the
miRNA (since some of the miRNAs have very similar sequences),
we applied three different levels of error tolerance, 0 mismatch
(termed Strategy 0), 1 mismatch (termed Strategy 1) and 2
mismatches (termed Strategy 2) for the endogenous sequence
mapping. The remaining unmapped sequences were then
compared to sequences from the known human microbiome,
miRNA sequences from other species, and the non-redundant
nucleic acid sequence collection from NCBI without any mismatch
allowance. To our surprise, a significant number of the unmapped
reads aligned with various bacterial and fungal sequences
(Figure 2a and Table S5).
Exogenous RNA is also Observed in Other Sample Types
To eliminate the possibility of bacteria and fungi contamination
during plasma preparation and handling, we generated sequenc-
ing libraries from other types of samples including human tissue
(commercially obtained normal lung RNA), bovine milk (com-
mercial whole milk), and mouse plasma (C57BL/6J), and
proceeded through the same analysis scheme. Sequences from
bacteria, fungi and other species can also be seen in these samples
(Figure 2b and Table S6). The overall percentages of exogenous
sequences for mouse plasma were lower compared to human
plasma samples. The human lung tissue had a very small fraction:
less than 1% under strategies 1 and 2, of the processed sequences
were from exogenous sources. The commercially obtained milk
contains a significant fraction of sequences attributable to bacteria.
To ensure that the exogenous sequences we observed were not
derived from any contaminated instruments or reagents, we
analyzed two public domain NextGen sequencing data sets:
SRR332232, serum small RNA sequencing results from a normal
Chinese individual [15], and SRR014350, yeast transcriptome
data from a yeast culture [16]. The yeast culture should not have
any exogenous sequences since it was grown in a sterile, defined
culture media. The yeast dataset yielded less than 0.15% of the
reads mapped to sequences other than yeast (Figure 2c and Table
S7), a level that is fully attributable to coincidence caused by
sequencing errors. Using our sequencing analysis pipeline, by
contrast, we observed that about 12% of the sequences in human
serum sample were from various exogenous species under Strategy
2.
To exclude the possibility that the observed exogenous RNAs
were from intact bacteria and fungi contamination in our plasma
samples, we used the 0.2 uM filter commonly used in tissue culture
to eliminate bacteria and fungi contamination, to filter the plasma
samples before RNA isolation. We did not observe any significant
difference in exogenous RNA levels between filtered and unfiltered
plasma, using QPCR primers specific to Pseudomonas putida 16S
RNA and Ceratocystiopsis minuta 18S RNA, matching the results for
the human 28S rRNA (Figure S2).
Human Plasma Contains Sequences that Map to a
Diverse Group of Microbiome Species
Based on the results from simulated dataset, allowing 2
mismatches should identify more than 98% of the endogenous
sequences (Table S4). Therefore, the exogenous sequence map-
ping results from Strategy 2 (2 mismatches allowed for endogenous
sequence mapping steps and no mismatch allowed in exogenous
sequence mapping) were used for further analysis.
Bacteria and archaea. We observed reads from plasma
covering all major bacteria phyla and two archaea phyla
(Euryarchaeota and Crenarchaeota) (Figure 3a and Table S8). We did
not observe any significant difference in the sequence distribution
patterns among plasma samples from normals and patients with
either colorectal cancer or ulcerative colitis (Table S8). Firmicutes,
typically the most abundant bacteria phylum in the human gut
microbiome [4], is the 3rd most abundant sequence population in
plasma.
A significant number of the reads mapped to bacteria are from
various ribosomal RNAs and tRNAs. High sequence similarity of
these sequences among different microbial species can lead to
misassignment of sequence reads. Thus, to increase the reliability
of mapping results, we removed reads that mapped to bacterial
rRNAs and tRNAs and reanalyzed the remaining reads.
Removing rRNA and tRNA sequences affected our ability to
detect species from Chloroflexi, Deferribacteres, Fibrobacteres and other
phyla (Figure 3a open bars and Table S8). However, the
Proteobacteria was still the most abundant phylum followed by
Bacteroidetes and Firmicutes.
The bacterium that accounts for the highest number of reads is
an uncultured bacterium. This is followed by Pseudomonas fluorescens,
an important beneficial bacterium in agricultural settings [17]
(Figure 3b). After removing the tRNA and rRNA reads, bacteria
from the genus Ralstonia spp. become the most abundant source
followed by Achromobascter piechaudii, a bacterium identified in some
clinical blood samples (Figure 3c) [18].
Fungi. Fungi represent the largest source of exogenous RNA,
about 14% of the processed reads under the Strategy 2 in our
plasma samples (Table S5). Like bacteria, the species mapped
covered all major fungal phyla, and Ascomycota is the most
abundant phylum either with or without considering rRNA and
tRNA reads (Figure 3d and Table S8). We could not detect species
from Microsporidia following the removal of rRNA and tRNA
sequences.
Exogenous RNA in Human Plasma
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Metarhizium anisopliae, a common fungus in soil had the most
mapped reads and Thielavia terrestris, a thermophilic fungus became
the species with the most abundant reads after removing tRNA
and rRNA sequences (Figure 3e and 3f). Either with or without
rRNAs and tRNAs reads, we observed a significant number of
reads mapped to yeast (Saccharomyces cerevisiae) which is commonly
used in baking and brewing (Figure S3).
Plasma also Contains Exogenous RNA Sequences from
Common Foods
After carefully examining the sequences mapped to species
other than bacteria and fungi, we observed a significant number of
processed reads that mapped to common food items. As we did for
bacteria and fungi, we removed all the reads that mapped to
rRNAs and tRNAs to increase the accuracy of mapping results.
We did not analyze sequences mapped to metazoan species since
the risk of coincidental sequence match caused by sequencing
error is much higher between human and other metazoan
samples. The most abundant food item derived RNA sequences
identified from our plasma samples then are corn (Zea mays)
followed by rice (Oryza sativa Japonica Group) (Figure 4a). The
number of mapped reads to corn is 66 times higher on average
than rice. In comparing the data from a serum sample from a
Chinese individual (downloaded from the public domain:
SRR332232), we found that the sequence abundance between
corn and rice is reversed: rice has the highest number of reads,
about 55-fold times the number from corn (Figure 4b). Besides the
common cereal grains, we also observed RNA from other food
items including soybeans (Glycine max), tomato (Solanum lycopersicum),
grape (Vitis vinifera) and others in our plasma samples (Figure 4c).
Plasma Contains Exogenous miRNAs from Other Species
Our sequencing results also revealed the presence of exogenous
miRNAs from other species. Due to the extreme sequence
similarity of miRNA sequences among some species, it is often
difficult to determine the exact origin of those exogenous miRNAs.
Some of the highly abundant exogenous miRNA species detected
in our plasma samples are listed in Table 1. Except for miR-168a
from the common cereal grains such as corn or rice, the rest of the
exogenous miRNAs were from various common household insects,
including the housefly, mosquito and bees. One interesting
observation is the high variation in the number of reads among
individual donors for those insect miRNAs. This was probably
caused by the different living conditions and levels of contami-
Figure 1. The schema of the sequence mapping protocol. A ‘‘map and remove’’ process was adapted to map reads against various sequence
databases (left dotted box) in specific order as indicated. We allowed different levels of sequence mismatch tolerance, 0 mismatch, 1 mismatch and 2
mismatches when comparing the sequence reads against human sequence database.
doi:10.1371/journal.pone.0051009.g001
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nated food consumed by our donors, but this remains to be
investigated.
The Exogenous RNA may form Complexes with Proteins
and Lipid in Plasma
It has been shown that the endogenous miRNAs can form
complexes with proteins or be packaged in various lipid vesicles
protecting them from abundant RNase in plasma [4,19,20,21,22].
To explore the stability of exogenous miRNAs and RNAs in
circulation, we treated the plasma samples with DNAse, protease,
Trixon X-100, and additional RNase before RNA isolation. Like
endogenous miRNA (miR-16), the levels of specific exogenous
miRNA (miR-263a-5p) and RNA (16S rRNA from Pseudomonas
putida) were reduced significantly after Triton X-100, protease,
RNase, and protease followed by RNase treatments (Figure S4).
Adding additional RNase caused less reduction compared to
protease followed by RNase treatments. This suggests that some of
the exogenous RNA molecules, like endogenous miRNAs, are
probably associated with protein and/or lipid complexes in
circulation and a fraction of those complexes may not be tightly
bound, such that the freeze thawing process or incubation at 37uC
during enzyme treatment may release some of the protected
RNAs.
Exogenous RNA Sequences Observed in Plasma can
Affect Cellular Gene Expression Pattern
While the functions of extracellular miRNAs are not fully
understood, it has been demonstrated that certain cells can take up
the miRNA contained in lipid vesicles, which results in changing
the cell’s gene expression profile [19]. To explore the potential
Figure 2. Distribution of sequence reads from human plasma (A), other sample types (B) and public domain data (C) among
different sequence categories. The sample identifies were listed on the top, the sequence mapping criteria were indicated on the bottom and
the list of different sequence categories is indicated on the right of each figure. See text for detailed description of Strategy 0, Strategy 1 and Strategy
2 sequence mapping criteria.
doi:10.1371/journal.pone.0051009.g002
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functions of exogenous RNAs in circulation, we transfected several
synthetic, double-stranded mature microRNA-like molecules
selected from observed exogenous miRNA sequences and some
highly abundant exogenous sequences (bacterial rRNAs) that have
potential to form pre-miRNA-like secondary structures (Figure S5)
into a mouse, Dicer-deficient, fibroblast cell line. Because of the
lack of the Dicer protein, a key RNAse III, miRNA processing
enzyme, the Dicer deficient cells contain very much less mature
miRNA compared to normal cells. This provides a good tool for
studying the function of miRNAs. By introducing individual
miRNA into these cells and avoiding multiple interactions of
microRNA and mRNA (Wang et al in preparation) it is possible to
interrogate the cells for mRNA levels, which are informative as to
specific miRNA function. Based on microarray profiling results, it
is clear that the expression profiles of a number of genes in the cells
were affected by some of the exogenous RNA sequences. We
verified the changes in levels of some of these affected genes’
mRNA by QPCR (Table S2 and Figure S6). The pathways
enriched among those down-regulated genes are listed in Table 2.
Two of the insect miRNAs, miR-263a-5p and bantam, did not
produce any significant effects on the cellular transcriptome, which
suggests that the process of transfection itself was not the cause of
the observed gene expression changes. This observation suggests
that RNA sequences in plasma might have some biological effects
on human cells.
Figure 3. Distribution of sequence reads from human plasma mapped to bacteria, archaea (A to C) and fungi (D to F) phylum. The Y-
axes are the numbers of reads in log 10 value and individual phylum are indicated on the X-axis. The number of reads used in the figures represents
the average of all 9 plasma samples used in the study. The solid bars represent the total number of processed reads mapped to specific phyla while
open bars are the number after removing rRNA and tRNA reads. The individual bacteria and fungi species with the most abundant processed reads (B
and E) and processed reads after removing tRNA and rRNAs (C and F) are also shown.
doi:10.1371/journal.pone.0051009.g003
Figure 4. Number of sequence reads mapped to common food items such as cereal grains (A) and others (B). The Y-axes are the
number of reads in log 10 value and individual species are indicated on the X-axis. The number of reads used in the figures represented the averages
from all 9 plasma samples used in the study. Figure 4C shows the difference in the abundance of reads mapped to common cereal gains between
serum sample from a Chinese individual (open bars) and the plasma samples (Caucasian) used in the study (solid bars).
doi:10.1371/journal.pone.0051009.g004
Exogenous RNA in Human Plasma
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Exogenous RNA Sequences can be Detected in RISC
Complex
It has been reported that cells in culture can take up
microvesicles and internalize its molecular contents including
RNA [23,24]. Since some of the exogenous RNAs in circulation
were packaged in lipid vesicles, we investigated whether the
cellular machinery involved in small RNA function could
incorporate exogenous RNA sequences. We compared the
exogenous RNA spectrum between fetal bovine serum used in
cell culture and intracellular RNA associated with RISC complex,
immunoprecipitated by argonaute 2 (Ago2), a key component of
the complex. Mass spectrometry based proteomic analysis on
immunoprecipitated proteins revealed the presence of Ago2 along
with several DDXs (DEAD box, helicase domain containing
proteins), hnRNPs (heterogeneous nuclear ribonucleoprotiens) and
RRMs (RNA recognition motif containing proteins) proteins as
reported earlier [25] (Table S9). The presence of Ago2 in the
immunoprecipitated protein mixture was also verified by Western
blot (Figure S7).
Compared to the total exogenous RNA in human plasma
samples (Table S5), the exogenous RNA populations associated
with RISC complex are significantly smaller (ranging from 4% to
16%, depending on search criteria) (Table 3). The exogenous
RNA population in fetal bovine serum was even lower than found
associated with the RISC complex. Looking carefully at the
sequences we obtained, there are a number of sequences that
mapped to various bacterial transcripts that were present in both
the RISC complex and fetal bovine serum (examples see Table 4,
full list on Table S10). Some of the regions contain these sequences
can form miRNA precursor like hairpin structure (Figure 5). This
observation further supports the suggestion that exogenous RNA
sequences may influence the function of cells through a miRNA-
like mechanism.
Discussion
Since most of the circulating endogenous RNAs we identified
originate from specific microbiome species, different conditions,
benign and pathological, may skew the circulating RNA popula-
tion. It may be surprising that we did not observe any significant
differences in the general spectrum of endogenous and exogenous
RNAs in circulation between samples from patients and normal
individuals used in this study. This is probably caused by the high
degree of heterogeneity of circulating RNA among individuals and
the small sample size used. Imprecise diagnosis can also
complicate the linkage between disease and circulating RNA
population. Larger sample sizes with well documented patholog-
Table 2. Affected pathways by transfecting the synthetic exogenous RNA sequences.
Exogenous RNA Sequence Species Affected pathways P-Value
AE1:GAACUGAAGAGUUUGAUCAUGG 16S rRNA from Pseudomonas Apoptosis 3.90E-03
Oocyte meiosis 1.50E-02
Small cell lung cancer 1.60E-02
RNA degradation 2.00E-02
Proteasome 4.80E-02
Pathways in cancer 5.40E-02
Spliceosome 6.50E-02
Pentose phosphate pathway 7.50E-02
Huntington’s disease 9.90E-02
AE2:AUUUACUGUCUGAGCUGGGUGG 23S rRNA from Rhodococcus Renal cell carcinoma 6.70E-03
Chronic myeloid leukemia 8.40E-03
Regulation of actin cytoskeleton 3.10E-02
Neurotrophin signaling pathway 3.50E-02
Tight junction 3.80E-02
MAPK signaling pathway 5.80E-02
Chemokine signaling pathway 8.00E-02
ErbB signaling pathway 8.40E-02
Focal adhesion 9.70E-02
AE3:CAGGCGUAGCCGAUGGACAACG 23S rRNA from Rhodococcus Pathways in cancer 1.20E-02
Adipocytokine signaling pathway 1.50E-02
Pancreatic cancer 1.80E-02
Focal adhesion 1.90E-02
Endocytosis 7.20E-02
Cell cycle 7.80E-02
RNA degradation 8.00E-02
AE4:CGAAUAGGGCGAUCGUAGUGGC 23S rRNA from Rhodococcus No enriched pathway
miR-263:AAUGGCACUGGAAGAAUUCACGG miR-263a from mosquito No enriched pathway
Bantam:UGAGAUCAUUGUGAAAGCUGAUU Bantam from house fly No enriched pathway
doi:10.1371/journal.pone.0051009.t002
Exogenous RNA in Human Plasma
PLOS ONE | www.plosone.org 8 December 2012 | Volume 7 | Issue 12 | e51009
ical conditions or using animal models in a controlled environment
will be used to shed further light on this observation.
It has long been thought that the human body is highly
insulated from its environment by two major protective mecha-
nisms, an active and dynamic immune system, and the body’s
physical barrier represented by skin, gut epithelium, mucus
membranes etc… While some sequences mapped to known
human transcripts and other genomic sequences, we were
surprised, even after very stringent screening criteria, to see that
a significant proportion of the sequencing reads from human
plasma samples in our study clearly originated from various
microbes, insects and food sources (Figure 2a). We used simulated
(Table S4) and public domain datasets (Figure 2c), and also
examined several different types of samples, to ensure our
sequence mapping protocol reliably assigns the endogenous
sequences, and we employed a number of controls to eliminate
the possibility of contamination in our samples and reagents.
Treating the plasma samples with DNAse prior to RNA isolation
has little or no effect on the levels of exogenous sequences, but the
levels of these sequences decreased by about 2 fold when the
plasma samples were treated with RNase (Figure S4). This
provides support for the conclusion that most of the exogenous
Figure 5. Examples of exogenous RNAs observed in fetal bovine serum and associated with RISC complex isolated from 293T cells
that may generate miRNA precursor like hairpin structure. The regions indicated by black brackets lines were observed in sequencing results
and listed on Table 4. RNAfold web server (www.rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi) was used to generate the putative secondary structure.
doi:10.1371/journal.pone.0051009.g005
Table 3. Comparing sequence distribution between RNA associated with RISC complexes from 293T cells and fetal bovine serum
using different mapping criteria.
Sample 293T cells Ago2 IP Bovine Serum
Search method Strategy 0 Strategy 1 Strategy 2 Strategy 0 Strategy 1 Strategy 2
Endogenous Sequence 26.12% 37.43% 47.69% 8.67% 11.72% 13.50%
Bacteria Sequencea 13.00% 9.07% 3.79% 0.28% 0.07% 0.04%
Fungi Sequencea 0.26% 0.13% 0.06% 0.09% 0.04% 0.02%
Other Sequencea 2.45% 0.60% 0.31% 0.99% 0.21% 0.11%
Unmapped Sequences 58.16% 52.78% 48.14% 89.97% 87.96% 86.33%
aTo increase the sequence mapping accuracy, we did not allow any sequence mismatch except in the endogenous sequence search step.
doi:10.1371/journal.pone.0051009.t003
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sequences in our results derive from RNA rather than DNA. To
escape enzymatic degradation, these RNA molecules probably
form complexes with proteins and/or lipid molecules, as has been
previously reported for endogenous miRNAs, since treating the
plasma samples with protease and Triton further decreased the
levels of these exogenous RNA molecules (Figure S4).
The ability to accurately assign the origin of exogenous
sequences is dependent on the availability of genome sequences
from each species. Even though the genomes from a significant
number of species have been determined in recent years, the
number is insignificant compared to the number of species in the
biota, particularly bacteria, archea and fungi. This includes many
species in the human microbiome. Although we could not
determine the origin of those exogenous RNA sequences with
complete confidence, the diverse and numerous reads that showed
perfect matches to a wide range of known microbial sequences
suggest the spectrum of RNA in the blood appears to reflect the
population of the gut, including the microbiome composition.
Interestingly, samples derived from the human gastrointestinal
tract were recently found to be significantly enriched in small
RNAs when compared to microbial community samples derived
from other environmental settings [26]. This finding along with
the results of the present work suggest that the human
gastrointestinal microbiota may disproportionately synthesizing
small RNA molecules which are then reflected in human blood. In
addition, the finding of a significant amount of RNA mapping to
common cereal grains including corn, rice and wheat (Figure 4)
clearly indicates that part of the RNA spectrum in the circulation
is also provided directly from food intake.
The existence of exogenous RNAs in circulation is intriguing for
several reasons. These molecules could possibly be molecular
waste in the process of degradation and elimination by the body,
and they could represent potential nutrients destined for further
degradation and absorption. However, we cannot easily explain
how such a large molecules as these RNAs must be enter the blood
stream through the gut epithelium. Most of these RNAs are likely
to be complexed with proteins and lipids, allowing them to escape
RNase degradation. In addition, we note that these RNA
molecules could influence cellular mRNA expression if they are
taken up by cells. We demonstrated this by transfecting synthetic
RNA sequences from some of the more abundant exogenous
sequences we found in plasma samples. We also found the same
(identical) bacteria sequences from fetal bovine serum in the RISC
complex of cultured cell lines (Table 4 and Table S10). Even
though the concentration of RNA we use in transfection (10 nM) is
much higher compared to plasma (,0.3 pM based on an average
of 100 ng/ml of RNA in plasma with an average of 100 nucleotide
in length and the selected RNA sequence represents less than
0.01% of the total RNA population), we cannot exclude the
possibility that certain cells in the body have an active uptake
system which can pick up the circulating RNA (both endogenous
and exogenous RNAs) at low concentrations. The recent finding of
the rice miR-168a which has an estimated serum concentration in
fM level in various mouse tissues further supports the possibility of
an active uptake system for some cells to take up low
concentration, circulating RNA [15] into their intracellular
compartments. Although extracellular nucleic acids in plasma
were discovered almost 60 years ago [27], the identification of
stable extracellular miRNA in circulation supports the the
fundamental idea of RNA-mediated signaling processes between
cells. If some of the exogenous RNAs we find in circulation have
the potential to influence cellular activity, individuals having
different levels of these RNAs from normal food intake or from
different microbiome populations could be affected by these
differences in unexpected ways. The complex interactions of diet,
microbiome and the cellular functions of the body, are affected in
turn by genetics, which suggests new dimensions of the gene-
environment interaction spectrum.
During the review process of this manuscript, Semenov et al
reported the finding of exogenous RNAs that mapped to microbial
sequences including Escherichia, Acinetobacter, Propionibacterium and
others in normal human plasma using a SOLiD sequencing
platform [28]. This independent study adds to the evidence we
present here and supports the idea of exogenous RNA present in
circulation as a common phenomenon in humans.
The finding of diverse exogenous RNA molecules in plasma,
and their potential influence on cellular gene expression, raises
several interesting questions about how humans interact with their
environments and particularly with their gastrointestinal biota.
Though the interaction between microbes and gut epithelium is
yet to be fully understood, some sort of feedback signaling process
might well be involved [6,29]. Peptides and small chemicals have
long been thought to be the two major types of signaling molecules
between microbe and gut epithelium. The finding of microbial
RNA in circulation now adds the possibility of an RNA-mediated
human-microbiome interaction as an additional communication
mechanism of this important axis for human health.
Materials and Methods
Ethics Statement
All protocols used in generating the mouse cell line were in
compliance with federal guidelines and under the approval of
Institute for Systems Biology’s Animal Care and Use Committee
Table 4. Examples of identical exogenous sequences observed in fetal bovine serum used in culture and RISC complex from
cultured cells.
Sequence ID Sequence Number of Reads Observed Sequence Mapped to
293T Ago2 IP Fetal Bovine Serum
Sequence 3 CATGGTCGGTCTTGTCGCTCTGG 2 2 Acidovorax ebreus Hypothetical protein
Sequence 10 GTTGATAGGTCAGGTGTGGAAGCG 12 8 Variovoras paradoxus EPS 23S rRNA
Sequence 21 CTTGTGTAGGATAGGTGGGAGGCT 2 1 Pseudomonas fluorescens 23S rRNA
Sequence 24 AGCAGTGGGGAATTTTGGACAAT 2 1 Delftia sp. Cs1-4 16S rRNA
Sequence 26 CACAGGGCTCTGCTAAGTCGGCT 2 1 Sphingobium sp.5S rRNA
Sequence 28 GTAGATATTCGGAAGAACACCA 1 1 Uncultured bacterium 16S rRNA
doi:10.1371/journal.pone.0051009.t004
Exogenous RNA in Human Plasma
PLOS ONE | www.plosone.org 10 December 2012 | Volume 7 | Issue 12 | e51009
(01.01.10). Human samples used in this study were obtained
according to the principles expressed in the Declaration of
Helsinki, approved by the Ethics Review Committee at the
Russian Oncological Research Center (PG-ONC 2003/1) and
written informed consent was obtained from the patients.
Sample and RNA Isolation
Plasma samples were obtained from Proteogenex (Culver City,
CA). All samples were collected from donors with proper
approvals from institutional review boards. The plasma was
prepared from EDTA blood by centrifugation at 1,0006g for 15
minutes to separate the plasma and blood cells. Total RNA from
plasma was extracted from 100 ml of the sample using the
miRNeasy kit (Qiagen, Valencia, CA). The quality and quantity of
the RNA were evaluated with Agilent 2100 Bioanalyzer (Santa
Clara, CA) and NanoDrop 1000 spectrophotometer (Thermo
Scientific, Wilmington, DE). In average, we obtained about
100 ng of RNA per ml of plasma. As a control we also obtained
total RNA from Ambion (Life Technologies, Carlsbad, CA).
NextGen Sequencing Library Preparation
NextGen sequencing libraries were prepared with small RNA
sample preparation kits from Illumina (Illumina, San Diego, CA).
The 39 and 59 adapters, and the reverse transcription primer were
diluted in nuclease-free water to concentration specified by
Illumina. RNA isolated from 200 ml of plasma (pooled from two
100 ml isolations) was concentrated and mixed with the diluted 39
adapter in a final volume of 6 ml of nuclease free water. To
eliminate secondary structures, the tube was incubated at 70uC for
2 minutes, then immediately cooled on ice. The ligation reaction
was set by adding 1 mL of 106T4 RNL2 reaction buffer, 0.8 mL of
100 mM MgCl2, 1.5 mL of T4 RNA ligase 2, and 0.5 mL of
RNaseOUT RNase inhibitor (Life Technologies, Carlsbad, CA)
and then incubated at 22uC for 1 hour. After ligating the 39
adaptor, 1 mL of the 59 adapter, 1 mL of 10 mM ATP, and 1 mL of
T4 RNA Ligase were added, then incubated at 20uC for 4 hours.
For cDNA synthesis, 4 mL of RNA ligated with both 59 and 39
adaptors was mixed with 1 mL of diluted reverse transcription
primer and incubated at 70uC for 2 minutes, then cooled on ice.
2 mL of 56 first-strand synthesis buffer, 0.5 mL of 12.5 mM dNTP
mix, 1 mL of 100 mM DTT, and 0.5 mL of RNase OUT were
added to the annealed primer-template mixture. The sample was
then heated at 48uC for 3 minutes. One mL of SuperScript II
Reverse Transcriptase was added to the sample and incubated at
44uC for 1 hour. The first-strand cDNA was then amplified with
GX1 and GX2 primers using a condition as following: 98uC for 30
seconds, followed by 20 cycles of 10 seconds at 98uC, 30 seconds at
60uC, 15 seconds at 72uC, holding for 10 minutes at 72uC, then
holding at 4uC. Since the amount of RNA in plasma is low, we did
not use the small RNA-enriched fraction for sequencing library
preparation; rather we selected and purified the cDNA through
6% Novex TBE PAGE gel (Life Technologies, Carlsbad, CA) a
larger library insert size, covering 20 to 100 nucleotides in length.
By doing so, we expected to get lower percentage of sequence
reads for miRNA, but gain the ability to see the general spectrum
of RNA in plasma including other ncRNAs and degraded
messenger RNAs (mRNA). A 0.6 mL microcentrifuge tube was
punctured 4–5 times using a 21-gauge needle and placed in a
2 mL microcentrifuge tube. The gel was stained with ethidium
bromide then the gel fragments containing nucleotides of the
desired length were excised and placed in the punctured 0.6 mL
tube. The stacked tubes were centrifuged at 14,000 rpm for 2
minutes. 100 mL of gel elution buffer was added to the gel debris
and incubated at room temperature overnight with agitation to
elute the DNA. Following elution, the eluate and gel debris were
transferred to the top of a Spin-X filter and centrifuged at
14000 rpm for 2 minutes to remove the gel debris. The DNA was
purified by ethanol precipitation and resuspended in 10 mL of
resuspension buffer. The quality and quantity of the library was
assessed by using the Agilent 2100 Bioanalyzer with the DNA
1000 chip. The prepared library was then run on Illumina
GenomeAnalyzer IIx at the genomic facility at the Institute for
Systems Biology.
NextGen Data Analysis
We obtained over 20 million sequence reads per sample with 35
cycle runs on Illumina Genome Analyzer IIx (Table S1). After
trimming the adaptor sequences, removing low quality sequences,
adaptor only sequences, and sequences containing only polyA, we
generally had 2 to 4 million processed reads with an average
length of 23 nucleotides.
A NextGen sequence read simulator, ART (http://
bioinformatics.joyhz.com/ART/), was used to generate artificial
transcriptome data from human, mouse, bovine and yeast.
Transcript sequences from ENSEMBL and miRNA sequences
from miRBase were combined and used as reference sequences.
Illumina read error profile was selected for the program to
generate artificial reads with either 23 or 35 nucleotides in length,
from the reference sequences.
Sequence mapping scheme. The processed sequences were
first screened against endogenous (human) sequence databases
including known human miRNA, human transcripts, followed by
human genomic sequence. To get complementary and efficient
mapping results, the alignment tool Blast was used to search
miRNA, and Bowtie was used to search other large databases. For
the endogenous sequence mapping, except miRNA, we applied
three different levels of error tolerance: 0 mismatch (termed
Strategy 0), 1 mismatch (termed Strategy 1) and 2 mismatch
(termed Strategy 2). The remaining unmapped sequences were
then compared to sequences from the known human microbiome,
miRNA sequences from other species, and the non-redundant
nucleic acid sequence collection from NCBI. Due to the high
sequence similarity for miRNA, we did not allow any sequence
mismatch for both endogenous and exogenous miRNA mappings.
We also did not allow any sequence mismatches for exogenous
sequence mapping to increase the accuracy of mapping results
(Figure 1). Species classification was based on NCBI Taxonomy
database (http://www.ncbi.nlm.nih.gov/taxonomy).
Transfection
The mouse Dicer deficient (DCR 2/2) fibroblast cell line was
generated from a conditional cre-lox Dicer allele, transgenic
mouse available from JAX (http://jaxmice.jax.org/strain/006001.
html) kindly provided by Dr. Jacques Peschon. Part of the RNase
III domain encoded in the exon 23 of dicer gene was deleted
following cre excision. DCR 2/2 cells were maintained in
Dubecco’s modified Eagle’s medium with high glucose. The media
was supplemented with 10% FBS, 1% non-essential amino acid,
1% Glutamax. The cells were routinely incubated at 37uC in a
humidified atmosphere with 5% CO2.
LipofectamineRNAiMAX was purchased from Invitrogen (Life
Technologies, Carlsbad, CA). Exogenous RNA for transfection
was obtained from Ambion (Life Technologies, Carlsbad, CA) and
followed their custom miRNA design protocol. DCR2/2 cells
were seeded at a density of 16105 cells in 6-well tissue culture
plates 24 h prior to transfect with 10 nM of synthetic RNAs. Cells
exposed to transfection reagents only were used as control. After
24 hours in the transfection media, the cells were harvested for
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RNA isolation and the transfection efficiency was validated with
QPCR.
Microarray Analysis
The effects of exogenous RNAs on transcriptome were assessed
by using the Agilent mouse 46 44K microarray (Agilent, Santa
Clara, CA). Total RNAs were isolated with an miRNeasy column
(Qiagen, Valencia, CA), and both Cy3 and Cy5-labeled cRNA
samples were prepared with two color labeling kit (Agilent
Technologies, Santa Clara, CA) and then hybridized at 65uC for
17 h. Signal intensity was calculated from digitized images
captured by a scanner from Agilent (Santa Clara, CA), and data
analysis was performed by using GeneSpring GX software (Agilent
Technologies, Santa Clara, CA).
Immunoprecipitation
HEK 293T cells were maintained in DMEM containing 10%
FBS, 2 mM L-glutamine, 100 U/mL penicillin, and 100 mg/mL
streptomycin (Life Technologies, Carlsbad, CA). For immunopre-
cipitation, cells were rinsed twice in ice-cold PBS and lysed for
30 min on ice in NP40 lysis buffer (Life Technologies, Carlsbad,
CA) containing protease inhibitor cocktail (Thermo Fisher
Scientific, Rockford, IL) and RNAse inhibitor (Promega, Madison,
WI). Lysates were cleared by centrifugation at 13,000 rpm at 4uC
for 20 min. Cleared lysates were transferred to new tubes and pre-
adsorbed by incubating with Dynabeads protein G beads (Life
Technologies, Carlsbad, CA) pre-blocked with RNAse-free BSA
(Life Technologies, Carlsbad, CA) and yeast tRNA (Life Tech-
nologies, Carlsbad, CA) for 30 min at 4uC. Pre-adsorbed lysates
were transferred to new tubes containing pre-blocked Dynabeads
protein G beads coated with rabbit anti-Ago2 (clone C34C6; Cell
Signaling Technology, Danvers, MA) antibodies and incubated
overnight at 4uC with rocking. Beads were collected and washed
several times with lysis buffer. RNA was isolated from washed
beads using the miRNeasy kit (Qiagen, Valencia, CA) and
prepared for sequencing.
The immunoprecipitated protein mixture was enzymatically
digested with trypsin and desalted with C18 Ultramicrospin
columns (The Nest Group, Southborough, MA). After drying in a
speedvac (Thermo Fisher Scientific, Rockford, IL) the sample was
re-suspended and analyzed on a high-performance linear ion trap
LTQ-Orbitrap Hybrid mass spectrometer (Thermo Fisher Scien-
tific, Waltham, MA). The MS/MS scans were searched against a
human IPI database (version 3.38, decoy-combined) using
X!Tandem search algorithm to determine peptide identity. A
Proteinprophet probability score $0.7 (equals to ,2.0% false
positive rate) was set to filter the search data.
Quantitative Polymerase Chain Reaction
The levels of the exogenous miRNA species were quantified by
using a TaqMan microRNA assays (Life Technologies, Carlsbad,
CA). cDNA was synthesized with a TaqMan microRNA reverse
transcription kit (Life Technologies, Carlsbad, CA) from 2 mLof
total RNA isolated from samples by a miRNeasy kit (Qiagen,
Valencia, CA). Real-time RT-PCR was performed with StepO-
nePlus Real-Time PCR Systems (Life Technologies, Carlsbad,
CA). The PCR conditions were as follows: initial enzyme
activation and RNA denaturation at 95uC for 10 minutes,
followed by 40 cycles of 95uC for 15s, 60uC for 1 min.
For other transcripts, SYBR based QPCR was used. For each
sample, 6 mL of RNA was reverse transcribed using the miScript
kit (Qiagen, Valencia, CA). For direct QPCR from plasma, 1 mLof
plasma was mixed with 5 mL of RNase free water then heated at
95uC for 5 minutes prior to cDNA synthesis. cDNAs were diluted
2-fold and used 2 mLin SYBR-based QPCR reactions. The
primers used in the study are listed in Table S2. The PCR
fragments were cloned and sequenced to verify their origin.
To explore the stability of exogenous RNA in plasma, we
treated the plasma with RNase A from Fementas (Fementas,
Thermo Scientific, Wilmington, DE) at a concentration at 1 mg/
ml, DNase I (Fermentas, Thermo Scientific, Wilmington, DE) at a
concentration of 1 unit/ml, protease K (Fermentas, Thermo
Scientific, Wilmington, DE) at a concentration of 0.05 mg/ml,
0.1% triton6100, or protease K for 20 minutes followed by
additional RNase A at 1 ug/ml after heat inactivation of protease
K at 70uC for 10 minutes prior for RNA isolation.
Supporting Information
Figure S1 miR-134 and let-7a (labeled on top) showing
concentration differences between normal and patient
plasma samples determined by sequencing (A) and
QPCR (B). The Y-axis represents the level of miRNA in either
log 2 transformed read number (A) or 40-Ct value (B). The sample
types and number of samples (number in parentheses) are
indicated on the X-axis. The significance values (p value) from a
t test are indicated.
(TIF)
Figure S2 The level of exogenous RNA in plasma is not
generated from contaminated plasma. Primers specific for
three different highly abundant ribosomal RNA species from
Ceratocystiopsis minuta (fungus), Pseudomonas putida (bacterium) and
human were used in RNA isolated from plasma directly (solid bars)
and plasma that had been filtered by 0.2 uM filter (open bars).
(TIF)
Figure S3 Some sequence reads from plasma are
mapped to common yeast. The number of processed reads
(solid bars) and reads after removing tRNA and rRNA sequences
(open bars) that mapped to common yeast is shown in the figure.
The Y-axis represents the level of RNA in log 2 transformed read
number and the identity of all 9 individuals is indicated on the X-
axis.
(TIF)
Figure S4 The relative changes of RNA concentrations
after treating the plasma with DNase, RNase, Protease
and triton X-100. The plasma samples were treated with
various conditions (indicated on the top of the figure) prior to RNA
isolation. The Y-axis represents the relative concentration change
compare to no treatment determined by QPCR. The data
represent the average changes from 9 plasma samples. The black
bars represent the changes of an endogenous miRNA, miR-16, the
open bars are exogenous miRNA, miR-263 from mosquitos and
the gray bars are the 16S rRNA from Pseudomonas putida.
(TIF)
Figure S5 Exogenous RNAs that may generate miRNA
precursor like hairpin structure were selected for
transfection experiment. The regions indicated by red lines
were selected and used to generate synthetic RNA for transfection.
RNAfold web server (www.rna.tbi.univie.ac.at/cgi-bin/RNAfold.
cgi) was used to generate the secondary structure.
(TIF)
Figure S6 The levels of several endogenous mRNAs can
be affected by transfecting synthetic exogenous RNAs.
The identities of exogenous RNAs (AE1, AE2 and AE3) and
endogenous genes are indicated on the top of the figure. The black
bars are the changes of expression levels measured by microarray
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while gray bars represent the relative changes measured by QPCR
(average of 3 independent measurements).
(TIF)
Figure S7 The immunoprecipitation of Argonaute 2
protein (a) and validation by western blotting (b). The
size of molecular marker is labeled on the left.
(TIF)
Table S1 Sample information.
(DOCX)
Table S2 Primer sequences used in the study.
(DOCX)
Table S3 Sequence distribution under different search
criteria.
(DOCX)
Table S4 Sequence distribution using simulated RNA_-
seq data from different species.
(DOCX)
Table S5 Sequence distribution under different search
criteria for human plasma samples.
(DOCX)
Table S6 Sequence distribution under different search
criteria for different types of samples.
(DOCX)
Table S7 Sequence distribution under different search
criteria for two public domain sequences.
(DOCX)
Table S8 Distribution of exogenous sequences mapped
to microbiome based on kingdom and phylum.
(DOCX)
Table S9 List of proteins associated with argonaute 2
(Ago2).
(DOCX)
Table S10 List of identical exogenous sequences ob-
served in fetal bovine serum used in culture and RISC
complex from cultured cells.
(DOCX)
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